Ticks are small but mighty creatures that pose a significant threat to both wildlife and humans. With their ability to carry and transmit a wide range of pathogens, ticks have become a growing concern in the northern hemisphere. Richard Marconi, a molecular biologist at Virginia Commonwealth University, has dedicated his career to studying tick-borne diseases and developing innovative solutions to combat them.
Marconi’s lab houses the world’s largest collection of blood serum from wildlife, with samples infected with various tick-borne pathogens. This collection serves as a testament to the widespread prevalence of tick-borne illnesses in North America. As tick populations continue to expand and their ranges shift due to climate change, the risk of contracting these diseases only grows.
Ticks have been around for millions of years and have evolved sophisticated feeding mechanisms to thrive on their hosts. With the ability to remain undetected for days, ticks travel with their hosts, spreading pathogens wherever they go. As the planet warms, ticks are able to thrive in new regions, increasing the prevalence of tick-borne diseases.
One of the main concerns with the tick population boom is the transmission of diseases to humans. Lyme disease and anaplasmosis are just a few examples of illnesses that can be transmitted through tick bites. Marconi’s research has shown that a significant percentage of wild animals are infected with these pathogens, serving as reservoirs for future infections.
To combat the growing threat of tick-borne diseases, researchers like Marconi are working on developing vaccines against Lyme and other tick-borne illnesses. Other researchers are focusing on vaccines that target ticks themselves, aiming to reduce their populations and prevent the spread of diseases.
Despite these promising developments, the question remains: will these efforts be enough to curb the spread of tick-borne diseases? As tick populations continue to rise and their ranges expand, it is crucial to stay vigilant and take precautions to avoid tick bites. By raising awareness and investing in research, we can work towards a future where tick-borne diseases are no longer a major threat to public health. Tick-borne diseases are on the rise in Europe, with Lyme disease infections steadily climbing and cases of tick-borne encephalitis increasing by almost 400 percent over the past 30 years. As ticks’ ranges expand northward and human encroachment on wildlife habitats puts people in closer contact with these disease-carrying pests, the risk of contracting tick-borne illnesses continues to grow.
One particular concern is the emergence of new illnesses transmitted by ticks. In the early 2000s, a previously unknown allergen found in red meat started triggering allergic reactions in people in the south-eastern US. The lone star tick was identified as the source of this allergy to alpha-gal, a sugar found in mammalian meat. Since then, over 110,000 cases of alpha-gal syndrome have been reported in the US. This same tick also transmits the potentially fatal Heartland virus. In China, 33 emerging tick-borne diseases have been identified in recent decades, including Wetland virus.
Managing the spread of tick-borne diseases is challenging due to incomplete understanding of tick ecology. For example, efforts to reduce Lyme disease on Martha’s Vineyard by targeting white-footed mice, thought to be the ticks’ main pathogen reservoirs, were ineffective. Research revealed that ticks on the island actually preferred shrews to mice, highlighting the complexity of tick ecology.
To address the growing threat of tick-borne diseases, researchers are focusing on developing new vaccines. Lyme disease, caused by the corkscrew-shaped spirochaete bacteria Borreliella burgdorferi, is one of the most widespread tick-borne diseases globally. Early diagnosis and treatment with antibiotics can effectively treat Lyme disease, but challenges in diagnosis and persistent symptoms in some individuals underscore the need for improved prevention strategies.
One promising approach is the development of a new Lyme disease vaccine that targets the OspC protein, which offers broader protection against the various strains of Borreliella burgdorferi. This new vaccine aims to overcome the limitations of previous vaccines, such as the need for frequent boosters. By addressing the complex biology of the bacterium and its ability to evade the host’s immune system, researchers hope to develop a more effective tool for preventing Lyme disease and other tick-borne illnesses. Look for ticks in hidden areas like the armpits, groin, and scalp. If you find a tick, remove it carefully with tweezers, pulling straight out without twisting.
